Petition calls on FDA to pull powerful opioids from market

WASHINGTON ( – As lawsuits mount against opioid drugmakers around the country, one group is hoping to cut supply of certain painkillers at the source by asking the FDA to pull them from the market.

In their petition, representatives from the Association of State and Territorial Health Officials, National Safety Council, Physicians for Responsible Opioid Prescribing, American College of Medical Toxicology and Coalition to End the Opioid Epidemic urged the FDA that the risks of ultra-high dose opioids (UHDU) aren’t worth “modest” benefits.

Citing potential for misuse and overdose, the group argues that the FDA “should immediately seek removal of oral and transmucosal UHDU opioid analgesics from the market.” An FDA representative said the agency “is reviewing the petition and will respond directly to the petitioner.”

The petition pointed to OxyContin 80 mg, which is typically prescribed twice a day and IR oxycodone 30 mg, which is often prescribed four times a day, as examples.

The development comes as the United States continues to suffer from a opioid and addiction epidemic that’s claiming lives around the country. President Donald Trump recently declared the situation a national emergency.

Sponsored Content